REG - JPMorgan Sec.Plc Primary Health Props - Form 8.5 (EPT/RI)-Primary Health Properties plc
23/05/2025 11:15
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250523:nRSW0004Ka&default-theme=true
RNS Number : 0004K JPMorgan Securities Plc 23 May 2025
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED
INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: J.P. Morgan Securities Plc
(b) Name of offeror/offeree in relation to whose relevant securities this form Primary Health Properties plc
relates:
Use a separate form for each offeror/offeree
(c) Name of the party to the offer with which exempt principal trader is Corporate Broker to Primary Health Properties Plc
connected:
(d) Date dealing undertaken: 22 May 2025
(e) In addition to the company in 1(b) above, is the exempt principal trader Yes , Assura plc
making disclosures in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
12.5p ordinary Purchase 3,912,232 0.9960 GBP 0.9813 GBP
Sale 3,887,105 1.0020 GBP 0.9796 GBP
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of reference securities Price per unit
e.g. CFD e.g. opening/closing a long/short position, increasing/reducing a long/short
position
12.5p ordinary Equity Swap Decrease Long 157,878 0.9865 GBP
39,443 0.9879 GBP
75,219 0.9895 GBP
1,693 0.9915 GBP
27 23.4997 ZAR
896 24.0000 ZAR
Decrease Short 96,896 0.9859 GBP
27 23.4997 ZAR
896 23.9952 ZAR
Increase Long 26,101 0.9832 GBP
365 0.9845 GBP
561 0.9864 GBP
965 0.9865 GBP
1,548 0.9876 GBP
27,164 0.9877 GBP
4,876 0.9878 GBP
10,856 0.9930 GBP
448 0.9950 GBP
69,429 1.0019 GBP
Increase Short 6,135 0.9866 GBP
11,895 0.9892 GBP
1,098 0.9940 GBP
2,461 0.9975 GBP
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the exempt
principal trader making the disclosure and any party to the offer or any
person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If
there are no such agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the exempt principal trader making the disclosure and any other person
relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
Date of disclosure: 23 May 2025
Contact name: Hetvi Shah
Telephone number: 44 2034 936359
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
(http://www.thetakeoverpanel.org.uk) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FERSELFSDEISESIRecent news on Primary Health Properties
See all newsREG - BlackRock Group Primary Health Props - Form 8.3 - Primary Health Properties plc
AnnouncementREG - Syquant Capital Primary Health Props Assura plc - Form 8.3 - PHP LN
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Primary Health Properties plc
AnnouncementREG - Evelyn Partners Grp Assura plc Primary Health Props - Form 8.3 - PRIMARY HEALTH PROPERTIES PLC
AnnouncementREG - Stifel Nicolaus Euro Assura plc Primary Health Props - Form 8.5 (EPT/RI) - Assura Plc
Announcement